Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 181.48 |
| Open | 178.50 |
| Bid | 182.50 x 1200 |
| Ask | 182.66 x 1100 |
| Day's range | 177.00 - 182.77 |
| 52-week range | 115.03 - 321.30 |
| Volume | |
| Avg. volume | 4,808,779 |
| Market cap | 70.055B |
| Beta (5Y monthly) | 1.73 |
| PE ratio (TTM) | 6.59 |
| EPS (TTM) | 27.67 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 209.47 |
- Simply Wall St.
44%of this Moderna, Inc. (NASDAQ:MRNA) insider's holdings were sold in the last year
Looking at Moderna, Inc.'s ( NASDAQ:MRNA ) insider transactions over the last year, we can see that insiders were net...
- Motley Fool
Moderna Stock: Buy, Sell, or Hold in 2023?
Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.
- Zacks
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
© 2022 Yahoo. All rights reserved.
